April 14 (Reuters) - The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its ...

By Sriparna Roy April 14 (Reuters) - The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury ...

By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

April 16 (Reuters) - Eli Lilly said on Thursday its newly approved obesity pill helped reduce the risk of major ...

By Sneha S K March 31 (Reuters) - Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal valued at up to $7.8 billion as the U.S. drugmaker looks to diversify beyond its metabolic ...

April 1 (Reuters) - Eli Lilly (LLY.N), opens new tab shares jumped nearly 6% on Wednesday after the U.S. Food and Drug Administration approved its weight-loss pill, Foundayo, marking a significant ...

A U.S. appeals court on Thursday revived a patent lawsuit that Teva Pharmaceutical brought against Eli ​Lilly over the companies' competing migraine drugs, after a judge ‌previously overturned a $176.

By Amina Niasse NEW YORK, April 9 (Reuters) - Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight ...

March 19 (Reuters) - Eli Lilly (LLY.N), opens new tab's next-generation obesity drug showed a significant reduction in blood sugar levels and weight in a late-stage trial, the company said on Thursday ...

By Mrinalika Roy April 2 (Reuters) - Eli Lilly's newly approved weight-loss pill is expected to generate billions in sales as ...

March 29 (Reuters) - Generative-AI drug developer Insilico Medicine (3696.HK), opens new tab said on Sunday it has agreed a global licensing and research deal ‌with U.S. drugmaker Eli Lilly (LLY.N), ...